Table 1.
IC50 Values for New Triazine Analogues.
Name of Compound | Formula Weight | OV 90 | A2780 | MCF-7 | MDA-MB231 | A549 | H1299 | HT-29 |
---|---|---|---|---|---|---|---|---|
TZ9 | 366.3 | 60 | 7.8 | 5 | 4.6 | 7.2 | 45 | 8.3 |
3a | 245.24 | 75 | 7.3 | 5.9 | 2.6 | 7.8 | 65 | 3.3 |
3b | 275.27 | 80 | 14.7 | 6.2 | 7.6 | 5.2 | 65 | 5.4 |
3c | 259.27 | 60 | 5.5 | 16 | 12.7 | 9.3 | 40 | 4.5 |
3d | 275.27 | 90 | 5.6 | 11.8 | 15.7 | 7.5 | 50 | 8.6 |
3e | 279.69 | 85 | 36.6 | 8.8 | 24.6 | 7.5 | 30 | 4.6 |
6a | 397.43 | 8 | 7.1 | 6 | 2.5 | 14.6 | 11 | 9.5 |
6b | 457.48 | 12 | 6.3 | 7.2 | 4.2 | 10.8 | 5 | 5.8 |
6c | 425.49 | 5 | 3.6 | 4.2 | 3.5 | 11.6 | 22 | 5.2 |
6d | 457.48 | 10 | 5 | 7.2 | 3.9 | 6.9 | 26 | 8.9 |
6e | 466.32 | 60 | 8.2 | 4.2 | 3.5 | 7.8 | 15 | 4.1 |
As described in the methods, the MTS assay was used to evaluate cell survival in the presence of each new triazine analogue in the range of 0 to 125 μM concentrations. For each cell line, the MTS assays were performed at least three independent experiments and each time in triplicates. The results presented in the table are average values from multiple experiments. The IC50 values were calculated from the data of % survival vs. drug concentration using Microsoft Excel 2010.